https://clinicaltrials.gov/ct2/show/NCT03877718?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Conditions : Migraine; Pain; Nausea; Vomiting; Aura
Interventions : Drug: Arm 1: CL-H1T; Drug: Arm 2: CL-H1T; Drug: Arm 3: Sumatriptan Succinate 100 mg capsule; Drug: Arm 4: Promethazine HCl 18.75 mg; Drug: Arm 5: Promethazine HCl 37.5 mg; Other: Placebo
Sponsor : Charleston Laboratories, Inc
Recruiting
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
NCT03877718
Mon, 18 Mar 2019 12:00:00 EDT
Last Update Posted: 03/18/19 10:46AM
